A long-lasting formulation of an antiviral drug greatly reduced people’s risk of a symptomatic flu infection in a trial, and ...

Influenza is considered one of the main public health problems in developed countries, being responsible for epidemics that affect 10% of the population each year. Influenza viruses can also cause ...

Company shares doubled on Phase 2 study results suggesting its drug could become an alternative to vaccines for flu ...

Despite national medical guidelines supporting the use of antiviral medications in young children diagnosed with influenza, a recent study reports an underuse of the treatment. "Antiviral Use ...

NanoViricides highlighted several key reasons for prioritizing MPox as the first indication for NV-387's Phase II development, even with strong efficacy data in animal studies for other major viral ...

Influenza continues to pose a significant global health burden, with seasonal outbreaks causing substantial morbidity and ...

Cidara Therapeutics has reported encouraging top-line outcomes from the Phase IIb NAVIGATE trial of the investigational ...

Pneumagen has announced the publication of phase 2 data showing its antiviral therapy, Neumifil, significantly reduced ...

The likelihood of antiviral prescribing and dispensing among patients with influenza varied by care setting, patient age, and underlying medical conditions.

Influenza A (H1N1)pdm09 virus resistance to baloxavir, oseltamivir and sialic acid mimetics in single and dual therapies: Insights from human airway epithelia and murine models. Antiviral Res. 2025 ...

Assess your risk of contracting H1N1 swine flu with our easy-to-use Swine Flu Risk Calculator. Identify risk factors, ...

A 41-year-old woman from northwestern Cambodia's Siem Reap province has been confirmed for H5N1 human avian influenza, ...